Single ascending dose study of S 649266

Trial Profile

Single ascending dose study of S 649266

Phase of Trial: Phase I

Latest Information Update: 08 Jan 2018

At a glance

  • Drugs Cefiderocol (Primary)
  • Indications Gram-negative infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Shionogi
  • Most Recent Events

    • 08 Jan 2018 Combined results of single and multiple ascending dose studies published in the Antimicrobial Agents and Chemotherapy
    • 28 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top